Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2010-12-10

Thelin (sitaxentan) to be withdrawn due to cases of unpredictable serious liver injury

View source ↗

Summary

Thelin (sitaxentan) is being withdrawn due to reports of unpredictable serious liver injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thelin (sitaxentan)